
|Slideshows|February 7, 2019
Migraine Treatment Advances Spell Relief
Author(s)Leo Robert
Find concise summaries of the latest management recommendations and research findings in this brief highlights slideshow.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
2
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
3
Tolebrutinib Approved in EU for Nonrelapsing Secondary Progressive MS, Marking First Disability-Targeting Therapy in the Indication
4
Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action
5


















